Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model-Reference-Cited by-同舟云学术

Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model

Published:2012-08 Issue:1 Volume:430 Page:10-19
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Bourgine Maryline,Dion Sarah,Godon Ophélie,Guillen Gerardo,Michel Marie-Louise,Aguilar Julio Cesar

Publisher

Elsevier BV

Subject

Virology

Reference33 articles.

1. Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen;Aguilar;Immunol. Cell Biol.,2004

2. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice;Babinet;Science,1985

3. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens;Betancourt;Int. J. Infect. Dis.,2007

4. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma;Bocher;Hepatology,1999

5. Hepatitis B virus immunopathogenesis;Chisari;Annu. Rev. Immunol.,1995

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuban Prophylactic and Therapeutic Vaccines for Controlling Hepatitis B;MEDICC Review;2021

2. Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32;EBioMedicine;2020-09

3. Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine;Antiviral Research;2018-05

4. Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand;The Lancet Gastroenterology & Hepatology;2018-03

5. ABX203, a novel therapeutic vaccine for chronic hepatitis B patients;Almanac of Clinical Medicine;2016-09-29